Botox may not only provide a nonsurgical face-lift — it may also lift your spirits, new research suggests. By paralyzing the facial muscles used for frowning, Botulinum Toxin A — or Botox — prevents ...

Revance Therapeutics' share price has been characterised by volatility ever since its IPO - but today shares trade close to an all-time low. The company's focus is on maximising the potential of ...

Opinions expressed by Entrepreneur contributors are their own. Clichéd as it may have become, there’s still real wisdom to be gleaned from the phrase “fake it until you make it.” Acting the part is ...

The US Food and Drug Administration (FDA) has approved daxibotulinumtoxinA-lanm injection (Daxxify) for the temporary improvement in the appearance of moderate to severe glabellar lines (frown lines) ...

PASADENA, Calif. (KABC) -- Botox is the number one requested non-invasive cosmetic procedure on the market. But the well-known brand is starting to show its age with many saying it doesn't work as ...

With a product so anticipated that some mistakenly refer to it by the name of its company, Revance Therapeutics may soon have an identity issue. The FDA has now approved Revance’s long-awaited Botox ...

Neuromodulator injections like Botox have become a cornerstone of modern aesthetic treatments for reducing facial wrinkles. These injections act to weaken specifically targeted facial muscles, ...

Neurotoxin injectables have become one of the most common non-surgical cosmetic treatments for smoothing wrinkles and ...

A new antiwrinkle drug threatens Botox’s three-decade dominance of the facial injectables market. The challenger is DaxibotulinumtoxinA-lanm or Daxxify, a neuromodulator protein that, like Botox, can ...

One year and another FDA inspection later, Revance has been hit with a second round of manufacturing citations, adding another wrinkle to its approval bid for a potential Botox rival. After an FDA ...